Orthobiologics Market CAGR is expected to be 4.39% during the forecast period and the market size is expected to reach nearly US$ 8.07 Bn. by 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report
Global Orthobiologics Market Dynamics:
Orthobiologics refer to biologics and cellular therapies in orthopedics made of a range of products such as recombinant growth factors, bone void fillers, stem cells, and grafts. Orthobiologics are also called regenerative cellular therapies. Increased incidences of sports injury, road accidents, and osteoarthritis, growing obese and geriatric population, and consumer preference towards the adoption of minimally invasive surgeries are expected to drive the global orthobiologics market. Orthopedic disorders caused by accident and trauma are increased exponentially, which will further boost the growth of the orthobiologics market. Spinal fusion is a primary application in the global orthobiologics market owing to the growing usage of demineralized bone matrices, bone morphogenetic proteins, and autografts and allografts in spinal fusion surgeries. Spinal fusion has the capability to speed up the bone healing process and it also offers high bone stability, smoothing long-term improvement of spinal disorders. It also helps to fast stimulation of cells to empower bone formation and avoids hospital stays and pedestrian visits. Viscosupplementation business segment is estimated to lead the global orthobiologics market. The leading position in the market is credited to the increasing adoption of orthobiologics owing to the extensive range availability and unique adoption in diseases like Osteoarthritis and hip degenerative joint disease. Viscosupplementation offers benefits like enhanced knee movement, pain reduction, less-invasive, and fewer side effects.Regional Insights:
North America is expected to dominate the global orthobiologics market during the forecast period. The dominant position in the market is attributed to the growing incidences of spinal disorders, growing the geriatric and obese population, rising preference for nominally invasive procedures, and growing physician and patient awareness about innovative treatment procedures and technologies. In this region, the United States is expected to hold the US xx Mn market share in the orthobiologics market. Furthermore, Asia Pacific is expected to grow at a xx % rate of CAGR in the global orthobiologics market during the forecast period. The government initiatives to an expansion of the healthcare infrastructure, the booming medical tourism industry in developing countries like India, Thailand, and Indonesia are expected to share significant growth in the orthobiologics market in this region. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding dynamics, structure by analysing the market segments and, project the global orthobiologics market. The report also provides a clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global orthobiologics market. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders in arranging the efforts and investment in the near future to a particular market segment.Orthobiologics Market, Key Highlights:
Global Orthobiologics Market analysis and forecast, in terms of value. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Orthobiologics Market Global Orthobiologics Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. Orthobiologics Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. Global Orthobiologics Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Orthobiologics Market are also profiled.Scope of the Report for Orthobiologics Market: Inquire before buying
Orthobiologics Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 5.97 Bn. Forecast Period 2023 to 2029 CAGR: 4.39% Market Size in 2029: US $ 8.07 Bn. Segments Covered: by Product Viscosupplementation Products Demineralized Bone Matrix Synthetic Orthobiologics Bone Morphogenetic Protein Allografts Plasma-Rich Protein Bone Marrow Aspirate Concentrate by Type Knee Ankle Hip Wrist & Shoulder Spine Others by Application Osteoarthritis and Degenerative Arthritis Spinal Fusion Fracture Recovery Soft Tissue Injuries Maxillofacial and Dental Applications by End-User Hospitals, Orthopedic Clinics, and Ambulatory Care Centers Research and Academic Institutes Dental Clinics and Facilities Orthobiologics Market, By Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)Key players are:
1.Stryker Corporation 2.Depuy Synthes 3.Xtant Medical Holdings, Inc. 4.Zimmer Biomet Holdings, Inc., 5.Wright Medical Group, Inc., 6.Integra Life Sciences Holdings Corporation 7.Arthrex, Inc. 8.Medtronic PLC. 9.Exactec Inc. 10.Orthofix International N.V. 11.Medline Industries, Inc. 12.Globus Medical, Inc., 13.Harvest Technologies Corporation 14.NuVasive Inc. 15.K2M Group Holdings, Inc. 16.RTI Surgical, Inc. 17.Seaspine Holdings Corporation 18.Korus Biosciences AG 19.Xtant Medical 20.Bioventus LLC 1. Which region has the largest share in Global Orthobiologics Market? Ans: Asia Pacific region holds the highest share in 2022. 2. What is the growth rate of Global Orthobiologics Market? Ans: The Global Orthobiologics Market is growing at a CAGR of 4.39% during forecasting period 2023-2029. 3. What is scope of the Global Orthobiologics Market report? Ans: Global Orthobiologics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 5. What is the study period of this market? Ans: The Global Orthobiologics Market is studied from 2022 to 2029.
Global Orthobiologics Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Orthobiologics Market Size, by Market Value (US$ Bn) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Global Orthobiologics Market Industry Trends 4.8. Global Orthobiologics Market Competitive Landscape 5. Supply Side and Demand Side Indicators 6. Global Orthobiologics Market Analysis and Forecast 6.1. Global Orthobiologics Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Orthobiologics Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Orthobiologics Market Value Share Analysis, by Product 7.4. Global Orthobiologics Market Size (US$ Bn) Forecast, by Product 7.5. Global Orthobiologics Market Analysis, by Product 7.6. Global Orthobiologics Market Attractiveness Analysis, by Product 8. Global Orthobiologics Market Analysis and Forecast, by Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Orthobiologics Market Value Share Analysis, by Type 8.4. Global Orthobiologics Market Size (US$ Bn) Forecast, by Type 8.5. Global Orthobiologics Market Analysis, by Type 8.6. Global Orthobiologics Market Attractiveness Analysis, by Type 9. Global Orthobiologics Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Orthobiologics Market Value Share Analysis, by End User 9.4. Global Orthobiologics Market Size (US$ Bn) Forecast, by End User 9.5. Global Orthobiologics Market Analysis, by End User 9.6. Global Orthobiologics Market Attractiveness Analysis, by End User 10. Global Orthobiologics Market Analysis and Forecast, by Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Orthobiologics Market Value Share Analysis, by Application 10.4. Global Orthobiologics Market Size (US$ Bn) Forecast, by Application 10.5. Global Orthobiologics Market Analysis, by Application 10.6. Global Orthobiologics Market Attractiveness Analysis, by Application 11. Global Orthobiologics Market Analysis, by Region 11.1. Global Orthobiologics Market Value Share Analysis, by Region 11.2. Global Orthobiologics Market Size (US$ Bn) Forecast, by Region 11.3. Global Orthobiologics Market Attractiveness Analysis, by Region 12. North America Orthobiologics Market Analysis 12.1. Key Findings 12.2. North America Orthobiologics Market Overview 12.3. North America Orthobiologics Market Value Share Analysis, by Product 12.4. North America Orthobiologics Market Forecast, by Product 12.4.1. Viscosupplementation Products 12.4.2. Demineralized Bone Matrix 12.4.3. Synthetic Orthobiologics 12.4.4. Bone Morphogenetic Protein 12.4.5. Allografts 12.4.6. Plasma-Rich Protein 12.4.7. Bone Marrow Aspirate Concentrate 12.5. North America Orthobiologics Market Value Share Analysis, by Type 12.6. North America Orthobiologics Market Forecast, by Type 12.6.1. Knee 12.6.2. Ankle 12.6.3. Hip 12.6.4. Wrist & Shoulder 12.6.5. Spine 12.6.6. Others 12.7. North America Orthobiologics Market Value Share Analysis, by End User 12.8. North America Orthobiologics Market Forecast, by End User 12.8.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 12.8.2. Research and Academic Institutes 12.8.3. Dental Clinics and Facilities 12.9. North America Orthobiologics Market Value Share Analysis, by Application 12.10. North America Orthobiologics Market Forecast, by Application 12.10.1. Osteoarthritis and Degenerative Arthritis 12.10.2. Spinal Fusion 12.10.3. Fracture Recovery 12.10.4. Soft Tissue Injuries 12.10.5. Maxillofacial and Dental Applications 12.11. North America Orthobiologics Market Value Share Analysis, by Country 12.12. North America Orthobiologics Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Orthobiologics Market Analysis, by Country 12.14. U.S. Orthobiologics Market Forecast, by Product 12.14.1. Viscosupplementation Products 12.14.2. Demineralized Bone Matrix 12.14.3. Synthetic Orthobiologics 12.14.4. Bone Morphogenetic Protein 12.14.5. Allografts 12.14.6. Plasma-Rich Protein 12.14.7. Bone Marrow Aspirate Concentrate 12.15. U.S. Orthobiologics Market Forecast, by Type 12.15.1. Knee 12.15.2. Ankle 12.15.3. Hip 12.15.4. Wrist & Shoulder 12.15.5. Spine 12.15.6. Others 12.16. U.S. Orthobiologics Market Forecast, by End User 12.16.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 12.16.2. Research and Academic Institutes 12.16.3. Dental Clinics and Facilities 12.17. U.S. Orthobiologics Market Forecast, by Application 12.17.1. Osteoarthritis and Degenerative Arthritis 12.17.2. Spinal Fusion 12.17.3. Fracture Recovery 12.17.4. Soft Tissue Injuries 12.17.5. Maxillofacial and Dental Applications 12.18. Canada Orthobiologics Market Forecast, by Product 12.18.1. Viscosupplementation Products 12.18.2. Demineralized Bone Matrix 12.18.3. Synthetic Orthobiologics 12.18.4. Bone Morphogenetic Protein 12.18.5. Allografts 12.18.6. Plasma-Rich Protein 12.18.7. Bone Marrow Aspirate Concentrate 12.19. Canada Orthobiologics Market Forecast, by Type 12.19.1. Knee 12.19.2. Ankle 12.19.3. Hip 12.19.4. Wrist & Shoulder 12.19.5. Spine 12.19.6. Others 12.20. Canada Orthobiologics Market Forecast, by End User 12.20.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 12.20.2. Research and Academic Institutes 12.20.3. Dental Clinics and Facilities 12.20.4. Healthcare and Life Sciences 12.21. Canada Orthobiologics Market Forecast, by Application 12.21.1. Osteoarthritis and Degenerative Arthritis 12.21.2. Spinal Fusion 12.21.3. Fracture Recovery 12.21.4. Soft Tissue Injuries 12.21.5. Maxillofacial and Dental Applications 12.22. North America Orthobiologics Market Attractiveness Analysis 12.22.1. By Product 12.22.2. By Type 12.22.3. By End User 12.22.4. By Application 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Orthobiologics Market Analysis 13.1. Key Findings 13.2. Europe Orthobiologics Market Overview 13.3. Europe Orthobiologics Market Value Share Analysis, by Product 13.4. Europe Orthobiologics Market Forecast, by Product 13.4.1. Viscosupplementation Products 13.4.2. Demineralized Bone Matrix 13.4.3. Synthetic Orthobiologics 13.4.4. Bone Morphogenetic Protein 13.4.5. Allografts 13.4.6. Plasma-Rich Protein 13.4.7. Bone Marrow Aspirate Concentrate 13.5. Europe Orthobiologics Market Value Share Analysis, by Type 13.6. Europe Orthobiologics Market Forecast, by Type 13.6.1. Knee 13.6.2. Ankle 13.6.3. Hip 13.6.4. Wrist & Shoulder 13.6.5. Spine 13.6.6. Others 13.7. Europe Orthobiologics Market Value Share Analysis, by End User 13.8. Europe Orthobiologics Market Forecast, by End User 13.8.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 13.8.2. Research and Academic Institutes 13.8.3. Dental Clinics and Facilities 13.9. Europe Orthobiologics Market Value Share Analysis, by Application 13.10. Europe Orthobiologics Market Forecast, by Application 13.10.1. Osteoarthritis and Degenerative Arthritis 13.10.2. Spinal Fusion 13.10.3. Fracture Recovery 13.10.4. Soft Tissue Injuries 13.10.5. Maxillofacial and Dental Applications 13.11. Europe Orthobiologics Market Value Share Analysis, by Country 13.12. Europe Orthobiologics Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Orthobiologics Market Analysis, by Country 13.14. Germany Orthobiologics Market Forecast, by Product 13.14.1. Viscosupplementation Products 13.14.2. Demineralized Bone Matrix 13.14.3. Synthetic Orthobiologics 13.14.4. Bone Morphogenetic Protein 13.14.5. Allografts 13.14.6. Plasma-Rich Protein 13.14.7. Bone Marrow Aspirate Concentrate 13.15. Germany Orthobiologics Market Forecast, by Type 13.15.1. Knee 13.15.2. Ankle 13.15.3. Hip 13.15.4. Wrist & Shoulder 13.15.5. Spine 13.15.6. Others 13.16. Germany Orthobiologics Market Forecast, by End User 13.16.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 13.16.2. Research and Academic Institutes 13.16.3. Dental Clinics and Facilities 13.17. Germany Orthobiologics Market Forecast, by Application 13.17.1. Osteoarthritis and Degenerative Arthritis 13.17.2. Spinal Fusion 13.17.3. Fracture Recovery 13.17.4. Soft Tissue Injuries 13.17.5. Maxillofacial and Dental Applications 13.18. U.K. Orthobiologics Market Forecast, by Product 13.18.1. Viscosupplementation Products 13.18.2. Demineralized Bone Matrix 13.18.3. Synthetic Orthobiologics 13.18.4. Bone Morphogenetic Protein 13.18.5. Allografts 13.18.6. Plasma-Rich Protein 13.18.7. Bone Marrow Aspirate Concentrate 13.19. U.K. Orthobiologics Market Forecast, by Type 13.19.1. Knee 13.19.2. Ankle 13.19.3. Hip 13.19.4. Wrist & Shoulder 13.19.5. Spine 13.19.6. Others 13.20. U.K. Orthobiologics Market Forecast, by End User 13.20.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 13.20.2. Research and Academic Institutes 13.20.3. Dental Clinics and Facilities 13.21. U.K. Orthobiologics Market Forecast, by Application 13.21.1. Osteoarthritis and Degenerative Arthritis 13.21.2. Spinal Fusion 13.21.3. Fracture Recovery 13.21.4. Soft Tissue Injuries 13.21.5. Maxillofacial and Dental Applications 13.22. France Orthobiologics Market Forecast, by Product 13.22.1. Viscosupplementation Products 13.22.2. Demineralized Bone Matrix 13.22.3. Synthetic Orthobiologics 13.22.4. Bone Morphogenetic Protein 13.22.5. Allografts 13.22.6. Plasma-Rich Protein 13.22.7. Bone Marrow Aspirate Concentrate 13.23. France Orthobiologics Market Forecast, by Type 13.23.1. Knee 13.23.2. Ankle 13.23.3. Hip 13.23.4. Wrist & Shoulder 13.23.5. Spine 13.23.6. Others 13.24. France Orthobiologics Market Forecast, by End User 13.24.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 13.24.2. Research and Academic Institutes 13.24.3. Dental Clinics and Facilities 13.25. France Orthobiologics Market Forecast, by Application 13.25.1. Osteoarthritis and Degenerative Arthritis 13.25.2. Spinal Fusion 13.25.3. Fracture Recovery 13.25.4. Soft Tissue Injuries 13.25.5. Maxillofacial and Dental Applications 13.26. Italy Orthobiologics Market Forecast, by Product 13.26.1. Viscosupplementation Products 13.26.2. Demineralized Bone Matrix 13.26.3. Synthetic Orthobiologics 13.26.4. Bone Morphogenetic Protein 13.26.5. Allografts 13.26.6. Plasma-Rich Protein 13.26.7. Bone Marrow Aspirate Concentrate 13.27. Italy Orthobiologics Market Forecast, by Type 13.27.1. Knee 13.27.2. Ankle 13.27.3. Hip 13.27.4. Wrist & Shoulder 13.27.5. Spine 13.27.6. Others 13.28. Italy Orthobiologics Market Forecast, by End User 13.28.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 13.28.2. Research and Academic Institutes 13.28.3. Dental Clinics and Facilities 13.29. Italy Orthobiologics Market Forecast, by Application 13.29.1. Osteoarthritis and Degenerative Arthritis 13.29.2. Spinal Fusion 13.29.3. Fracture Recovery 13.29.4. Soft Tissue Injuries 13.29.5. Maxillofacial and Dental Applications 13.30. Spain Orthobiologics Market Forecast, by Product 13.30.1. Viscosupplementation Products 13.30.2. Demineralized Bone Matrix 13.30.3. Synthetic Orthobiologics 13.30.4. Bone Morphogenetic Protein 13.30.5. Allografts 13.30.6. Plasma-Rich Protein 13.30.7. Bone Marrow Aspirate Concentrate 13.31. Spain Orthobiologics Market Forecast, by Type 13.31.1. Knee 13.31.2. Ankle 13.31.3. Hip 13.31.4. Wrist & Shoulder 13.31.5. Spine 13.31.6. Others 13.32. Spain Orthobiologics Market Forecast, by End User 13.32.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 13.32.2. Research and Academic Institutes 13.32.3. Dental Clinics and Facilities 13.33. Spain Orthobiologics Market Forecast, by Application 13.33.1. Osteoarthritis and Degenerative Arthritis 13.33.2. Spinal Fusion 13.33.3. Fracture Recovery 13.33.4. Soft Tissue Injuries 13.33.5. Maxillofacial and Dental Applications 13.34. Rest of Europe Orthobiologics Market Forecast, by Product 13.34.1. Viscosupplementation Products 13.34.2. Demineralized Bone Matrix 13.34.3. Synthetic Orthobiologics 13.34.4. Bone Morphogenetic Protein 13.34.5. Allografts 13.34.6. Plasma-Rich Protein 13.34.7. Bone Marrow Aspirate Concentrate 13.35. Rest of Europe Orthobiologics Market Forecast, by Type 13.35.1. Knee 13.35.2. Ankle 13.35.3. Hip 13.35.4. Wrist & Shoulder 13.35.5. Spine 13.35.6. Others 13.36. Rest of Europe Orthobiologics Market Forecast, by End User 13.36.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 13.36.2. Research and Academic Institutes 13.36.3. Dental Clinics and Facilities 13.37. Rest Of Europe Orthobiologics Market Forecast, by Application 13.37.1. Osteoarthritis and Degenerative Arthritis 13.37.2. Spinal Fusion 13.37.3. Fracture Recovery 13.37.4. Soft Tissue Injuries 13.37.5. Maxillofacial and Dental Applications 13.38. Europe Orthobiologics Market Attractiveness Analysis 13.38.1. By Product 13.38.2. By Type 13.38.3. By End User 13.38.4. By Application 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Orthobiologics Market Analysis 14.1. Key Findings 14.2. Asia Pacific Orthobiologics Market Overview 14.3. Asia Pacific Orthobiologics Market Value Share Analysis, by Product 14.4. Asia Pacific Orthobiologics Market Forecast, by Product 14.4.1. Viscosupplementation Products 14.4.2. Demineralized Bone Matrix 14.4.3. Synthetic Orthobiologics 14.4.4. Bone Morphogenetic Protein 14.4.5. Allografts 14.4.6. Plasma-Rich Protein 14.4.7. Bone Marrow Aspirate Concentrate 14.5. Asia Pacific Orthobiologics Market Value Share Analysis, by Type 14.6. Asia Pacific Orthobiologics Market Forecast, by Type 14.6.1. Knee 14.6.2. Ankle 14.6.3. Hip 14.6.4. Wrist & Shoulder 14.6.5. Spine 14.6.6. Others 14.7. Asia Pacific Orthobiologics Market Value Share Analysis, by End User 14.8. Asia Pacific Orthobiologics Market Forecast, by End User 14.8.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 14.8.2. Research and Academic Institutes 14.8.3. Dental Clinics and Facilities 14.9. Asia Pacific Orthobiologics Market Value Share Analysis, by Application 14.10. Asia Pacific Orthobiologics Market Forecast, by Application 14.10.1. Osteoarthritis and Degenerative Arthritis 14.10.2. Spinal Fusion 14.10.3. Fracture Recovery 14.10.4. Soft Tissue Injuries 14.10.5. Maxillofacial and Dental Applications 14.11. Asia Pacific Orthobiologics Market Value Share Analysis, by Country 14.12. Asia Pacific Orthobiologics Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Orthobiologics Market Analysis, by Country 14.14. China Orthobiologics Market Forecast, by Product 14.14.1. Viscosupplementation Products 14.14.2. Demineralized Bone Matrix 14.14.3. Synthetic Orthobiologics 14.14.4. Bone Morphogenetic Protein 14.14.5. Allografts 14.14.6. Plasma-Rich Protein 14.14.7. Bone Marrow Aspirate Concentrate 14.15. China Orthobiologics Market Forecast, by Type 14.15.1. Knee 14.15.2. Ankle 14.15.3. Hip 14.15.4. Wrist & Shoulder 14.15.5. Spine 14.15.6. Others 14.16. China Orthobiologics Market Forecast, by End User 14.16.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 14.16.2. Research and Academic Institutes 14.16.3. Dental Clinics and Facilities 14.17. China Orthobiologics Market Forecast, by Application 14.17.1. Osteoarthritis and Degenerative Arthritis 14.17.2. Spinal Fusion 14.17.3. Fracture Recovery 14.17.4. Soft Tissue Injuries 14.17.5. Maxillofacial and Dental Applications 14.18. India Orthobiologics Market Forecast, by Product 14.18.1. Viscosupplementation Products 14.18.2. Demineralized Bone Matrix 14.18.3. Synthetic Orthobiologics 14.18.4. Bone Morphogenetic Protein 14.18.5. Allografts 14.18.6. Plasma-Rich Protein 14.18.7. Bone Marrow Aspirate Concentrate 14.19. India Orthobiologics Market Forecast, by Type 14.19.1. Knee 14.19.2. Ankle 14.19.3. Hip 14.19.4. Wrist & Shoulder 14.19.5. Spine 14.19.6. Others 14.20. India Orthobiologics Market Forecast, by End User 14.20.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 14.20.2. Research and Academic Institutes 14.20.3. Dental Clinics and Facilities 14.21. India Orthobiologics Market Forecast, by Application 14.21.1. Osteoarthritis and Degenerative Arthritis 14.21.2. Spinal Fusion 14.21.3. Fracture Recovery 14.21.4. Soft Tissue Injuries 14.21.5. Maxillofacial and Dental Applications 14.22. Japan Orthobiologics Market Forecast, by Product 14.22.1. Viscosupplementation Products 14.22.2. Demineralized Bone Matrix 14.22.3. Synthetic Orthobiologics 14.22.4. Bone Morphogenetic Protein 14.22.5. Allografts 14.22.6. Plasma-Rich Protein 14.22.7. Bone Marrow Aspirate Concentrate 14.23. Japan Orthobiologics Market Forecast, by Type 14.23.1. Knee 14.23.2. Ankle 14.23.3. Hip 14.23.4. Wrist & Shoulder 14.23.5. Spine 14.23.6. Others 14.24. Japan Orthobiologics Market Forecast, by End User 14.24.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 14.24.2. Research and Academic Institutes 14.24.3. Dental Clinics and Facilities 14.25. Japan Orthobiologics Market Forecast, by Application 14.25.1. Osteoarthritis and Degenerative Arthritis 14.25.2. Spinal Fusion 14.25.3. Fracture Recovery 14.25.4. Soft Tissue Injuries 14.25.5. Maxillofacial and Dental Applications 14.26. ASEAN Orthobiologics Market Forecast, by Product 14.26.1. Viscosupplementation Products 14.26.2. Demineralized Bone Matrix 14.26.3. Synthetic Orthobiologics 14.26.4. Bone Morphogenetic Protein 14.26.5. Allografts 14.26.6. Plasma-Rich Protein 14.26.7. Bone Marrow Aspirate Concentrate 14.27. ASEAN Orthobiologics Market Forecast, by Type 14.27.1. Knee 14.27.2. Ankle 14.27.3. Hip 14.27.4. Wrist & Shoulder 14.27.5. Spine 14.27.6. Others 14.28. ASEAN Orthobiologics Market Forecast, by End User 14.28.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 14.28.2. Research and Academic Institutes 14.28.3. Dental Clinics and Facilities 14.29. ASEAN Orthobiologics Market Forecast, by Application 14.29.1. Osteoarthritis and Degenerative Arthritis 14.29.2. Spinal Fusion 14.29.3. Fracture Recovery 14.29.4. Soft Tissue Injuries 14.29.5. Maxillofacial and Dental Applications 14.30. Rest of Asia Pacific Orthobiologics Market Forecast, by Product 14.30.1. Viscosupplementation Products 14.30.2. Demineralized Bone Matrix 14.30.3. Synthetic Orthobiologics 14.30.4. Bone Morphogenetic Protein 14.30.5. Allografts 14.30.6. Plasma-Rich Protein 14.30.7. Bone Marrow Aspirate Concentrate 14.31. Rest of Asia Pacific Orthobiologics Market Forecast, by Type 14.31.1. Knee 14.31.2. Ankle 14.31.3. Hip 14.31.4. Wrist & Shoulder 14.31.5. Spine 14.31.6. Others 14.32. Rest of Asia Pacific Orthobiologics Market Forecast, by End User 14.32.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 14.32.2. Research and Academic Institutes 14.32.3. Dental Clinics and Facilities 14.33. Rest of Asia Pacific Orthobiologics Market Forecast, by Application 14.33.1. Osteoarthritis and Degenerative Arthritis 14.33.2. Spinal Fusion 14.33.3. Fracture Recovery 14.33.4. Soft Tissue Injuries 14.33.5. Maxillofacial and Dental Applications 14.34. Asia Pacific Orthobiologics Market Attractiveness Analysis 14.34.1. By Product 14.34.2. By Type 14.34.3. By End User 14.34.4. By Application 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Orthobiologics Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Orthobiologics Market Overview 15.3. Middle East & Africa Orthobiologics Market Value Share Analysis, by Product 15.4. Middle East & Africa Orthobiologics Market Forecast, by Product 15.4.1. Viscosupplementation Products 15.4.2. Demineralized Bone Matrix 15.4.3. Synthetic Orthobiologics 15.4.4. Bone Morphogenetic Protein 15.4.5. Allografts 15.4.6. Plasma-Rich Protein 15.4.7. Bone Marrow Aspirate Concentrate 15.5. Middle East & Africa Orthobiologics Market Value Share Analysis, by Type 15.6. Middle East & Africa Orthobiologics Market Forecast, by Type 15.6.1. Knee 15.6.2. Ankle 15.6.3. Hip 15.6.4. Wrist & Shoulder 15.6.5. Spine 15.6.6. Others 15.7. Middle East & Africa Orthobiologics Market Value Share Analysis, by End User 15.8. Middle East & Africa Orthobiologics Market Forecast, by End User 15.8.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 15.8.2. Research and Academic Institutes 15.8.3. Dental Clinics and Facilities 15.9. Middle East & Africa Orthobiologics Market Value Share Analysis, by Application 15.10. Middle East & Africa Orthobiologics Market Forecast, by Application 15.10.1. Osteoarthritis and Degenerative Arthritis 15.10.2. Spinal Fusion 15.10.3. Fracture Recovery 15.10.4. Soft Tissue Injuries 15.10.5. Maxillofacial and Dental Applications 15.11. Middle East & Africa Orthobiologics Market Value Share Analysis, by Country 15.12. Middle East & Africa Orthobiologics Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Orthobiologics Market Analysis, by Country 15.14. GCC Orthobiologics Market Forecast, by Product 15.14.1. Viscosupplementation Products 15.14.2. Demineralized Bone Matrix 15.14.3. Synthetic Orthobiologics 15.14.4. Bone Morphogenetic Protein 15.14.5. Allografts 15.14.6. Plasma-Rich Protein 15.14.7. Bone Marrow Aspirate Concentrate 15.15. GCC Orthobiologics Market Forecast, by Type 15.15.1. Knee 15.15.2. Ankle 15.15.3. Hip 15.15.4. Wrist & Shoulder 15.15.5. Spine 15.15.6. Others 15.16. GCC Orthobiologics Market Forecast, by End User 15.16.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 15.16.2. Research and Academic Institutes 15.16.3. Dental Clinics and Facilities 15.17. GCC Orthobiologics Market Forecast, by Application 15.17.1. Osteoarthritis and Degenerative Arthritis 15.17.2. Spinal Fusion 15.17.3. Fracture Recovery 15.17.4. Soft Tissue Injuries 15.17.5. Maxillofacial and Dental Applications 15.18. South Africa Orthobiologics Market Forecast, by Product 15.18.1. Viscosupplementation Products 15.18.2. Demineralized Bone Matrix 15.18.3. Synthetic Orthobiologics 15.18.4. Bone Morphogenetic Protein 15.18.5. Allografts 15.18.6. Plasma-Rich Protein 15.18.7. Bone Marrow Aspirate Concentrate 15.19. South Africa Orthobiologics Market Forecast, by Type 15.19.1. Knee 15.19.2. Ankle 15.19.3. Hip 15.19.4. Wrist & Shoulder 15.19.5. Spine 15.19.6. Others 15.20. South Africa Orthobiologics Market Forecast, by End User 15.20.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 15.20.2. Research and Academic Institutes 15.20.3. Dental Clinics and Facilities 15.21. South Africa Orthobiologics Market Forecast, by Application 15.21.1. Osteoarthritis and Degenerative Arthritis 15.21.2. Spinal Fusion 15.21.3. Fracture Recovery 15.21.4. Soft Tissue Injuries 15.21.5. Maxillofacial and Dental Applications 15.22. Rest of Middle East & Africa Orthobiologics Market Forecast, by Product 15.22.1. Viscosupplementation Products 15.22.2. Demineralized Bone Matrix 15.22.3. Synthetic Orthobiologics 15.22.4. Bone Morphogenetic Protein 15.22.5. Allografts 15.22.6. Plasma-Rich Protein 15.22.7. Bone Marrow Aspirate Concentrate 15.23. Rest of Middle East & Africa Orthobiologics Market Forecast, by Type 15.23.1. Knee 15.23.2. Ankle 15.23.3. Hip 15.23.4. Wrist & Shoulder 15.23.5. Spine 15.23.6. Others 15.24. Rest of Middle East & Africa Orthobiologics Market Forecast, by End User 15.24.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 15.24.2. Research and Academic Institutes 15.24.3. Dental Clinics and Facilities 15.25. Rest of Middle East & Africa Orthobiologics Market Forecast, by Application 15.25.1. Osteoarthritis and Degenerative Arthritis 15.25.2. Spinal Fusion 15.25.3. Fracture Recovery 15.25.4. Soft Tissue Injuries 15.25.5. Maxillofacial and Dental Applications 15.26. Middle East & Africa Orthobiologics Market Attractiveness Analysis 15.26.1. By Product 15.26.2. By Type 15.26.3. By End User 15.26.4. By Application 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Orthobiologics Market Analysis 16.1. Key Findings 16.2. South America Orthobiologics Market Overview 16.3. South America Orthobiologics Market Value Share Analysis, by Product 16.4. South America Orthobiologics Market Forecast, by Product 16.4.1. Viscosupplementation Products 16.4.2. Demineralized Bone Matrix 16.4.3. Synthetic Orthobiologics 16.4.4. Bone Morphogenetic Protein 16.4.5. Allografts 16.4.6. Plasma-Rich Protein 16.4.7. Bone Marrow Aspirate Concentrate 16.5. South America Orthobiologics Market Value Share Analysis, by Type 16.6. South America Orthobiologics Market Forecast, by Type 16.6.1. Knee 16.6.2. Ankle 16.6.3. Hip 16.6.4. Wrist & Shoulder 16.6.5. Spine 16.6.6. Others 16.7. South America Orthobiologics Market Value Share Analysis, by End User 16.8. South America Orthobiologics Market Forecast, by End User 16.8.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 16.8.2. Research and Academic Institutes 16.8.3. Dental Clinics and Facilities 16.9. South America Orthobiologics Market Value Share Analysis, by Application 16.10. South America Orthobiologics Market Forecast, by Application 16.10.1. Osteoarthritis and Degenerative Arthritis 16.10.2. Spinal Fusion 16.10.3. Fracture Recovery 16.10.4. Soft Tissue Injuries 16.10.5. Maxillofacial and Dental Applications 16.11. South America Orthobiologics Market Value Share Analysis, by Country 16.12. South America Orthobiologics Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Orthobiologics Market Analysis, by Country 16.14. Brazil Orthobiologics Market Forecast, by Product 16.14.1. Viscosupplementation Products 16.14.2. Demineralized Bone Matrix 16.14.3. Synthetic Orthobiologics 16.14.4. Bone Morphogenetic Protein 16.14.5. Allografts 16.14.6. Plasma-Rich Protein 16.14.7. Bone Marrow Aspirate Concentrate 16.15. Brazil Orthobiologics Market Forecast, by Type 16.15.1. Knee 16.15.2. Ankle 16.15.3. Hip 16.15.4. Wrist & Shoulder 16.15.5. Spine 16.15.6. Others 16.16. Brazil Orthobiologics Market Forecast, by End User 16.16.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 16.16.2. Research and Academic Institutes 16.16.3. Dental Clinics and Facilities 16.17. Brazil Orthobiologics Market Forecast, by Application 16.17.1. Osteoarthritis and Degenerative Arthritis 16.17.2. Spinal Fusion 16.17.3. Fracture Recovery 16.17.4. Soft Tissue Injuries 16.17.5. Maxillofacial and Dental Applications 16.18. Mexico Orthobiologics Market Forecast, by Product 16.18.1. Viscosupplementation Products 16.18.2. Demineralized Bone Matrix 16.18.3. Synthetic Orthobiologics 16.18.4. Bone Morphogenetic Protein 16.18.5. Allografts 16.18.6. Plasma-Rich Protein 16.18.7. Bone Marrow Aspirate Concentrate 16.19. Mexico Orthobiologics Market Forecast, by Type 16.19.1. Knee 16.19.2. Ankle 16.19.3. Hip 16.19.4. Wrist & Shoulder 16.19.5. Spine 16.19.6. Others 16.20. Mexico Orthobiologics Market Forecast, by End User 16.20.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 16.20.2. Research and Academic Institutes 16.20.3. Dental Clinics and Facilities 16.21. Mexico Orthobiologics Market Forecast, by Application 16.21.1. Osteoarthritis and Degenerative Arthritis 16.21.2. Spinal Fusion 16.21.3. Fracture Recovery 16.21.4. Soft Tissue Injuries 16.21.5. Maxillofacial and Dental Applications 16.22. Rest of South America Orthobiologics Market Forecast, by Product 16.22.1. Viscosupplementation Products 16.22.2. Demineralized Bone Matrix 16.22.3. Synthetic Orthobiologics 16.22.4. Bone Morphogenetic Protein 16.22.5. Allografts 16.22.6. Plasma-Rich Protein 16.22.7. Bone Marrow Aspirate Concentrate 16.23. Rest of South America Orthobiologics Market Forecast, by Type 16.23.1. Knee 16.23.2. Ankle 16.23.3. Hip 16.23.4. Wrist & Shoulder 16.23.5. Spine 16.23.6. Others 16.24. Rest of South America Orthobiologics Market Forecast, by End User 16.24.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers 16.24.2. Research and Academic Institutes 16.24.3. Dental Clinics and Facilities 16.25. Rest of South America Orthobiologics Market Forecast, by Application 16.25.1. Osteoarthritis and Degenerative Arthritis 16.25.2. Spinal Fusion 16.25.3. Fracture Recovery 16.25.4. Soft Tissue Injuries 16.25.5. Maxillofacial and Dental Applications 16.26. South America Orthobiologics Market Attractiveness Analysis 16.26.1. By Product 16.26.2. By Type 16.26.3. By End User 16.26.4. By Application 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Stryker Corporation 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Company Footprint 17.3.2. Depuy Synthes 17.3.3. Xtant Medical Holdings, Inc. 17.3.4. Zimmer Biomet Holdings, Inc., 17.3.5. Wright Medical Group, Inc., 17.3.6. Integra Life Sciences Holdings Corporation 17.3.7. Arthrex, Inc. 17.3.8. Medtronic PLC. 17.3.9. Exactec Inc. 17.3.10. Orthofix International N.V. 17.3.11. Medline Industries, Inc. 17.3.12. Globus Medical, Inc., 17.3.13. Harvest Technologies Corporation 17.3.14. NuVasive Inc. 17.3.15. K2M Group Holdings, Inc. 17.3.16. RTI Surgical, Inc. 17.3.17. Seaspine Holdings Corporation 17.3.18. Korus Biosciences AG 17.3.19. Xtant Medical 17.3.20. Bioventus LLC 18. Primary Key Insights